Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study by Xiangjun Qi, Yanlong Li, Wei Liu, Yifan Wang, Zhuangzhong Chen, Lizhu Lin

“…The most productive institution was Genentech Inc., while Mem Sloan Kettering Canc Ctr was the most cited one. …”
Get full text

Understanding the Burdens Associated with Huntington’s Disease in Manifest Patients and Care Partners–Comparing to Parkinson’s Disease and the General Population by Alex Exuzides, Joana E. Matos, Anisha M. Patel, Ashley A. Martin, Bryan Ricker, Danny Bega

Get full text

Knowledge, attitude and practice on ovarian reserve function among women of childbearing age: a prospective cross-sectional study in Chongqing and surrounding regions by Li Yang, Yu Deng, Jun Hu, Hongying Zhang, Youfang Yuan

Get full text

Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study by G. Mattingly, M. Christensen, K. Simonsen, L. Hammer-Helmich, H. Ren

“…Mattingly has served as researcher, consultant or speaker for Akili, Alcobra, Alkermes, Allergan, Axsome, Boehringer, Forum, Genentech, Jansen, Lundbeck, Medgenics, Merck, Neos, NLS Pharma, Otsuka, Reckitt Benckiser, Roche, Sage, Shire, Sunovion, Supe …”
Get full text

S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPL... by Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chatree Chai-Adisaksopha, Teresita Dumagay, Roberta Demichelis, Martin Höglund, Richard Kelly, Je-Hwan Lee, Jun-Ichi Nishimura, Naoshi Obara, Antonio Maria Risitano, Anna Gaya, Anita Appius, Brittany Gentile, Raluca Negricea, Zilu Zhang, Simon Buatois, Bing Han

Get full text

Integrated systems modeling of severe asthma: Exploration of IL‐33/ST2 antagonism by Kapil Gadkar, Justin Feigelman, Siddharth Sukumaran, Manoj C. Rodrigo, Tracy Staton, Fang Cai, Rebecca N. Bauer, David F. Choy, Cynthia L. Stokes, Heleen Scheerens, Saroja Ramanujan

Get full text

Hallmarks of neurodegenerative disease: A systems pharmacology perspective by Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau‐Veilleux, Matthew Moye, Kazutaka Sekiguchi, Guy Meno‐Tetang, Aparna Mohan, R. Maithreye, Veena A. Thomas, Frank Gibbons, Antonio Cabal, Jean‐Marie Bouteiller, Hugo Geerts

Get full text

Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development by Siobhan Connor-Ahmad, Jorrit Tjeertes, Michael Chladek, Louise Newton, Tara Symonds, Susanne Clinch, Brenda Vincenzi, Fiona McDougall

Get full text

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy by Ranee Mehra, Ina Rhee, Naiyer Rizvi, Robert L Ferris, Hussein Tawbi, Matthew D Hellmann, Sarah B Goldberg, Ryan J Sullivan, Helen X Chen, Jong Chul Park, Foluso O Ademuyiwa, Z Alexander Cao

Get full text

Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression by DuPage, Michel J., Mazumdar, Claire, Winslow, Monte M., Bronson, Roderick T., Crowley, Denise G., Chen, Jianzhu, Cheung, Ann, Schmidt, Leah Marie, Jacks, Tyler E.

Get full text
Get full text
Get full text
Get full text

TNFi Cycling Versus Changing Mechanism of Action in TNFi‐Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study by Jeffrey R. Curtis, Joel M. Kremer, George Reed, Ani K. John, Dimitrios A. Pappas

Get full text

PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature by Samar Binkheder, Heng-Yi Wu, Sara K. Quinney, Shijun Zhang, Md. Muntasir Zitu, Chien‐Wei Chiang, Lei Wang, Josette Jones, Lang Li

Get full text

Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay by Andra B. Schromm, Wilmar Correa, Nicolas Gisch, Frank Steiniger, Walter Richter, Guillermo Martinez-de-Tejada, Klaus Brandenburg, Friedrich von Wintzingerode

Get full text

Increases in sensory noise predict attentional disruptions to audiovisual speech perception by Victoria L. Fisher, Victoria L. Fisher, Cassandra L. Dean, Cassandra L. Dean, Claire S. Nave, Emma V. Parkins, Emma V. Parkins, Willa G. Kerkhoff, Willa G. Kerkhoff, Leslie D. Kwakye

Get full text

OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models by Jinghui Zhan, Petia Mitchell, Juan Estrada, Jonathan Werner, Jason DeVoss, Pedro J Beltran, Jing Qing, Keegan S Cooke

Get full text

Post‐remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre‐ versus post‐VIALE‐A real‐world experience from a p... by Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Archibong Yellow‐Duke, Wei‐Han Cheng, Michael E. Werner, Jonathan Abbas, William Donnellan

Get full text

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment by González JM, Ogale S, Morlock R, Posner J, Hauber B, Sommer N, Grothey A

“…Juan Marcos González,1 Sarika Ogale,2 Robert Morlock,2 Joshua Posner,1 Brett Hauber,1 Nicolas Sommer,2 Axel Grothey3 1Health Preference Assessment Department, RTI Health Solutions, Research Triangle Park, NC, 2Genentech, South San Francisco, CA, 3Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA Objective: Many publications describe preferences for colorectal cancer (CRC) screening; however, few studies elicited preferences for anticancer-drug treatment for metastatic CRC (mCRC). …”
Get full text

Patched 1 reduces the accessibility of cholesterol in the outer leaflet of membranes by Maia Kinnebrew, Giovanni Luchetti, Ria Sircar, Sara Frigui, Lucrezia Vittoria Viti, Tomoki Naito, Francis Beckert, Yasunori Saheki, Christian Siebold, Arun Radhakrishnan, Rajat Rohatgi

Get full text

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors by Christian U. Blank, Deborah J. Wong, Thai H. Ho, Todd M. Bauer, Carrie B. Lee, Fabiola Bene-Tchaleu, Jing Zhu, Xiaosong Zhang, Edward Cha, Mario Sznol

Get full text

Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease by Mary T. Scott, Wei Liu, Rebecca Mitchell, Cassie J. Clarke, Ross Kinstrie, Felix Warren, Hassan Almasoudi, Thomas Stevens, Karen Dunn, John Pritchard, Mark E. Drotar, Alison M. Michie, Heather G. Jørgensen, Brian Higgins, Mhairi Copland, David Vetrie

Get full text